AI assistant
REPLIGEN CORP — Director's Dealing 2024
Sep 5, 2024
30826_dirs_2024-09-04_d3a26fa9-1127-4e4f-b887-832bd7212fe4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2024-09-03
Reporting Person: Hunt Anthony (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-03 | Common Stock | D | 13146 | $0.00 | Disposed | 152031 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-03 | Stock Option (Right to Buy) | $192.71 | D | 13057 | Disposed | 2034-02-27 | Common Stock (13057) | Direct |
Footnotes
F1: On June 28, 2024 (the "Effective Date"), the Issuer and Mr. Hunt entered into an amendment (the "2024 Equity Award Amendment") to certain of Mr. Hunt's equity awards, pursuant to which, effective as of September 1, 2024, Mr. Hunt forfeited two thirds of the number of shares of the Issuer's Common Stock underlying the time-based restricted stock unit award, performance-based restricted stock unit awards and stock option granted to Mr. Hunt on February 27, 2024 that remain outstanding as of the Effective Date.
F2: Pursuant to the 2024 Equity Award Amendment, one third of the remaining stock options will vest and become exercisable on February 27, 2025, February 27, 2026, and February 27, 2027.